This ASX financials stock has already doubled this year – Morgans thinks it can keep going!

Its not too late to buy this stock market winner according to Morgans.

Key points
  • Generation Development Group (ASX: GDG) shares have surged 109% in 2025, hitting record highs amid strong momentum in the ASX financials sector.
  • Morgans sees continued growth ahead, citing GDG’s record investment bond sales and robust quarterly performance.
  • The broker raised its price target to $8.01 and maintained an “Accumulate” rating, implying around 10% further upside potential.

It has been a fruitful year for many ASX financials stocks. 

The S&P/ASX 200 Financials (ASX:XFJ) index is up almost 14% year to date. 

Generation Development Group Ltd (ASX: GDG) has been one of those financials stocks steaming ahead. 

The diversified financial services business has seen its share price rise from $3.47 per share in January, to a closing price yesterday of $7.28. 

That represents a whopping 109% gain. 

It has surpassed all time high after all time high in that span. 

Many investors may look at that rise and think they have missed the boat. However the team at Morgans have upgraded their view on this ASX financials stock indicating there could be further growth ahead. 

Here's what the broker said yesterday. 

A kid stretches up to reach the top of the ruler drawn on the wall behind.

Image source: Getty Images

Record performance

The company reported strong FY25 results including impressive growth in revenue, NPAT and assets under management. 

The broker noted yesterday that GDG is off to a good start in FY 26 as well. 

Morgans said GDG's 1Q26 business update saw a record Investment Bond sales performance (+A$333m) that beat market expectations. 

The broker said other results were largely in line with expectations. 

Overall, Morgans saw this as a solid enough quarterly performance by GDG, displaying ongoing robust operating momentum.

Based on this analysis, the broker lifted its EPS forecasts by +1%-3% on slight increases to both Investment Bond sales and Evidentia AUM forecasts.

Updated price target from Morgans

Speaking on the potential for further growth, Morgans said: 

Our price target rises to A$8.01 on our earnings changes and a valuation roll-forward. We think GDG has a great story, and management has executed well over time. 

With the stock trading at a >10% discount to our price target, we maintain our Accumulate recommendation.

Based on yesterday's closing price of $7.28, this indicates an upside of 10.03%. Not bad for a stock that has already doubled in 2025.

Morgans isn't the only broker with an optimistic view on this ASX financials stock. 

Earlier this month, Bell Potter placed a buy rating and $8.20 price target on GDG shares. 

This indicates an upside of 12.64%. 

Motley Fool contributor Aaron Bell has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Generation Development Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A little girl wearing wonky glasses checks out what's happening in the world on a mobile phone.
Broker Notes

Buy, hold, sell: Paladin Energy, Accent, Sigma Healthcare shares

Experts reveal the reasons behind their new ratings.

Read more »

A woman looks excited as she fans out a wad of Aussie $100 notes.
Broker Notes

Macquarie predicts 90% upside and an 8% dividend yield for this ASX share

If the broker is right, this share will pay off nicely.

Read more »

a doctor in white coat and stethoscope stands in front of a building holding an electronic device in his hands.
Healthcare Shares

ASX 200 healthcare shares rebound 57% in 5 months. Here's 1 to buy and 1 to sell: experts

It's time to take profits on one share, while the other has more growth left, say these experts.

Read more »

Young man with a laptop in hand watching stocks and trends on a digital chart.
Broker Notes

Buy, hold, sell: Fortescue, Santos, CBA shares

Let's review some new expert ratings and insights on 3 ASX 200 heavyweights.

Read more »

An unhappy man in a suit sits at his desk with his arms crossed staring at his laptop screen as the PointsBet share price falls
Broker Notes

BHP, Westpac, CSL shares: Buy, sell, or hold?

One of these ASX shares is tipped to fall 13%.

Read more »

Woman tying up her shoelaces before a run.
Broker Notes

Buy, hold, sell: Coles, Wesfarmers, CSL shares

It's a new week and we've got new ratings from the experts.

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Two male ASX investors and executives wearing dark coloured suits sit at a table holding their mobile phones discussing the highest trading ASX 200 shares today
Broker Notes

Buy, hold, sell: Resmed, Goodman Group, CBA shares

We review three fresh buy, hold, and sell calls from John Athanasiou at Red Leaf Securities.

Read more »